Skip to content
HubProPlay

The Zimbabwean Government Declines ‘Lopsided’ American Healthcare Assistance Package Because of Information Concerns

Health funding image
The proposed American funding was intended for initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has rejected a significant American health deal valued at $367m (272 million pounds) spanning five years because of Washington's demand for confidential data.

This move became public after a internal memorandum dated December was leaked, revealing that President Emmerson Mnangagwa deemed the deal was "lopsided".

A government spokesman later explained that the United States was demanding access to health data for scientific study and profit while was not willing to guarantee the benefits from future medical innovations.

"We are forced to start the difficult and regrettable task of ending our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the US had furnished more than $1.9bn as health assistance to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has called for continued talks to secure a agreement suitable to both sides so the country's critical HIV programme can proceed.

Wider Context

Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a high court suspended a related health funding agreement following legal challenges were raised about the safety of citizens' medical information.

Since resuming office recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.

USAID had managed aid for the US government, but Trump stated its spending was "inefficient" and his administration was seeking direct bilateral deals to enhance openness and accountability.

Based on statements, 16 African countries have to date agreed to similar health pacts, representing more than $18.3bn in committed funds.

Details of the Declined Agreement

The funds for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"We are confident this collaboration might have yielded significant advantages for the people of Zimbabwe, especially the 1.2 million presently receiving antiretroviral therapy through US-supported programmes," the Ambassador added.

However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to share its genetic material and health information over an extended period, with no corresponding promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.

"In essence, our nation would provide the basic resources for scientific discovery without any certainty that the end products would be available to our people if a future health crisis emerge."

Sovereignty and Global Health

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were upending structures previously set up via the international organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to deal with potential global health emergencies.

"This mechanism is designed to guarantee that when a country contributes its information, the benefits – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to create them."

These objections over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We encourage further dialogue with our American counterparts on how subsequent collaboration could be arranged in a manner that honours the independence and interests of each country."

Medical Community Reaction

Medical experts expressed it understood the official position, but suggested that talks need to persist since much of the nation's HIV programmes were funded by external financing.

"In cases where specific concerns arise, such as those relating to data governance or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," it added.

The halted deal emphasises the continuing challenges between accepting much-needed international aid and protecting a country's data in an increasingly data-driven world.

Written by

Edward Banks

A passionate gamer and tech enthusiast with years of experience in esports journalism and community building.

HubProPlay

Type to search articles.